Agios Pharmaceuticals Inc (STU:8AP)
€ 56 0 (0%) Market Cap: 3.20 Bil Enterprise Value: 2.30 Bil PE Ratio: 5.18 PB Ratio: 2.06 GF Score: 28/100

Agios Pharmaceuticals Inc at Cowen HealthCare Conference Transcript

Mar 03, 2020 / 04:20PM GMT
Release Date Price: €41.99 (-2.14%)
Chris Shibutani
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Are we on? Okay. Great. Thank you very much. My name is Chris Shibutani, I'm a member of the Cowen biotech research team. Making sure that the microphone sounds here are working here. Very pleased to have Agios with us once again at our Cowen 40th Annual Conference here. Fireside chat format, which I think is a wonderful opportunity to really get more in depth, kick the tires on some issues for a story that has been long admired and is undergoing some very important transformations, which create a tremendous opportunity we feel for investors at this point in time. Joining me today, very pleased to have Jackie Fouse. Probably like the 1 year anniversary of your actually taking the...

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Just about. Yes.

Chris Shibutani
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Being in actually the seat, wearing the hat and the whole thing.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot